Wide clinical spectrum in a family with hereditary lymphedema type I due to a novel missense mutation in VEGFR3.
Article Details
- CitationCopy to clipboard
Spiegel R, Ghalamkarpour A, Daniel-Spiegel E, Vikkula M, Shalev SA
Wide clinical spectrum in a family with hereditary lymphedema type I due to a novel missense mutation in VEGFR3.
J Hum Genet. 2006;51(10):846-50. Epub 2006 Aug 19.
- PubMed ID
- 16924388 [ View in PubMed]
- Abstract
Hereditary lymphedema type I (HL-I), also known as Milroy disease, is an autosomal dominant disorder characterized by typical phenotype of infantile onset lower-limb lymphedema accompanied by variable expression of recurrent episodes of cellulites, toenail changes, and papillomatosis. Mutations in the vascular endothelial growth factor receptor 3 (VEGFR3), also known as FLT4 gene, which encodes a lymphatic endothelial-specific tyrosine kinase receptor, have been identified as a genetic cause of HL-I. We report a large Muslim Arab family residing in northern Israel with 14 individuals presenting clinical features of HL-I. Genetic analysis revealed novel missense mutation E1106K in the tyrosine kinase domain II of VEGFR3 that cosegregates with the disorder in the family. Most affected individuals presented with bilateral congenital lower-limb lymphedema. Wide intrafamilial phenotypic variability included two asymptomatic individuals, a case of prenatal hydrothorax evolving to hydrops fetalis, and a late-onset complication, yet unreported, of chronic degenerative joint disease of the knees. This report broadens the known "classic" phenotype of HL-I.